Barriers to symptom management in oncology. Background: 5-fluorouracil (5-FU) is widely used to treat solid tumors and is often administered via infusion pump at or near its maximum tolerated dose.

Central venous access devices in fluoropyrimidine therapy are associated with complications; however, reliable data are lacking regarding their natural history, associated complications and infusion ...

SAN FRANCISCO — The first and only antidote for a chemotherapy overdose appears to be a safe and effective life-saving emergency treatment. The product, uridine triacetate (Vistogard, Wellstat ...

Correlation of postoperative CEA trends with survival and patterns of recurrence after hepatectomy for colorectal cancer metastases. Background: 5-fluorouracil (5-FU) 50 years after its first ...

We performed a multicentre randomised trial to compare the efficacy and toxicity of 12 weeks of 5-fluorouracil (5-FU) delivered by protracted intravenous infusion (PVI 5-FU) against the standard bolus ...

Omitting bolus 5-fluorouracil (5-FU) from combination chemotherapy for gastrointestinal (GI) cancers did not adversely affect survival and was associated with less toxicity, a review of a large ...